BioZorb Breast Marker Lawsuit FilingsBelow are links to Pretrial Orders (PTOs), Case Management Orders (CMOs), and other key court filings that have been entered in the BioZorb Breast Marker Lawsuit.The BioZorb breast tissue marker litigation involves claims that the BioZorb implantable surgical marker, used after lumpectomy or breast-conserving surgery, caused chronic pain, infections, disfigurement, and inflammatory reactions in patients.The BioZorb lawsuits have been filed across the United States and are expected to be consolidated into a multidistrict litigation (MDL) for coordinated pretrial proceedings. This page will be updated regularly as new filings and pretrial orders are issued.(Bookmark this page to stay up to date as additional case management orders and filings are published.)BioZorb Breast Marker Lawsuit Filings10/16/2025: Scheduling Order – Pretrial and Bellwether Deadlines for Taylor, Deuel, Kresch, and Gibson Cases [PDF]About the BioZorb Breast Marker LawsuitThe BioZorb implantable surgical marker, manufactured by Hologic, Inc., was marketed as a 3D bioabsorbable device used to mark the site of breast tissue removal after lumpectomy. The device was intended to assist with radiation targeting and surgical follow-up imaging.However, numerous women have reported severe complications such as:Persistent breast pain and inflammationInfection and abscess formationImplant extrusion through the skinDisfigurement or deformityChronic fibrosis or tissue hardeningPlaintiffs allege that Hologic failed to properly warn patients and surgeons about these risks and that the BioZorb device was defectively designed and unreasonably dangerous for its intended use.Current StatusThe Judicial Panel on Multidistrict Litigation (JPML) is reviewing motions to centralize all BioZorb-related lawsuits in a single federal district court. Once established, this page will include:Pretrial Orders (PTOs)Case Management Orders (CMOs)Scheduling OrdersFact Sheet TemplatesDiscovery ProtocolsAnd other official filingsLearn More or Join the LitigationTo learn more about your legal rights or to see if you qualify for a BioZorb lawsuit, visit our BioZorb Breast Marker Lawsuit Information Page or call (202) 792-7927 for a free consultation with our product liability attorneys.

Question

Accepted Answer

BioZorb Breast Marker Lawsuit FilingsBelow are links to Pretrial Orders (PTOs), Case Management Orders (CMOs), and other key court filings that have been entered in the BioZorb Breast Marker Lawsuit.The BioZorb breast tissue marker litigation involves claims that the BioZorb implantable surgical marker, used after lumpectomy or breast-conserving surgery, caused chronic pain, infections, disfigurement, and inflammatory reactions in patients.The BioZorb lawsuits have been filed across the United States and are expected to be consolidated into a multidistrict litigation (MDL) for coordinated pretrial proceedings. This page will be updated regularly as new filings and pretrial orders are issued.(Bookmark this page to stay up to date as additional case management orders and filings are published.)BioZorb Breast Marker Lawsuit Filings10/16/2025: Scheduling Order – Pretrial and Bellwether Deadlines for Taylor, Deuel, Kresch, and Gibson Cases [PDF]About the BioZorb Breast Marker LawsuitThe BioZorb implantable surgical marker, manufactured by Hologic, Inc., was marketed as a 3D bioabsorbable device used to mark the site of breast tissue removal after lumpectomy. The device was intended to assist with radiation targeting and surgical follow-up imaging.However, numerous women have reported severe complications such as:Persistent breast pain and inflammationInfection and abscess formationImplant extrusion through the skinDisfigurement or deformityChronic fibrosis or tissue hardeningPlaintiffs allege that Hologic failed to properly warn patients and surgeons about these risks and that the BioZorb device was defectively designed and unreasonably dangerous for its intended use.Current StatusThe Judicial Panel on Multidistrict Litigation (JPML) is reviewing motions to centralize all BioZorb-related lawsuits in a single federal district court. Once established, this page will include:Pretrial Orders (PTOs)Case Management Orders (CMOs)Scheduling OrdersFact Sheet TemplatesDiscovery ProtocolsAnd other official filingsLearn More or Join the LitigationTo learn more about your legal rights or to see if you qualify for a BioZorb lawsuit, visit our BioZorb Breast Marker Lawsuit Information Page or call (202) 792-7927 for a free consultation with our product liability attorneys.

BioZorb Breast Marker Lawsuit Filings